当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 利润表

南京医药

(600713)

  

流通市值:65.63亿  总市值:66.75亿
流通股本:12.87亿   总股本:13.09亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入14,246,884,352.753,696,173,895.840,938,180,822.5227,232,110,530.43
营业收入14,246,884,352.753,696,173,895.840,938,180,822.5227,232,110,530.43
二、营业总成本13,943,368,597.8352,651,384,912.8840,123,096,334.3126,666,946,892.11
营业成本13,397,551,742.4750,323,077,943.0238,414,540,220.2525,552,871,035.22
税金及附加28,768,607.11116,270,967.7685,321,921.4154,788,761.23
销售费用291,361,696.081,148,152,134.81845,968,276.41557,873,681.7
管理费用98,418,095.61517,660,434.62346,175,353.89209,416,358.44
研发费用9,115,551.4830,635,024.7430,536,340.6522,290,489.93
财务费用118,152,905.08515,588,407.93400,554,221.7269,706,565.59
其中:利息费用69,466,148.85325,820,558.4266,514,175.23170,525,181.31
其中:利息收入6,069,321.1913,605,914.3910,172,311.346,395,645.21
加:公允价值变动收益353,888.89---
加:投资收益178,683.574,018,269.493,096,723.621,038,058.45
资产处置收益2,921,757.694,149,625.864,301,998.514,037,344.55
资产减值损失(新)2,164,228.26-18,267,214.45-2,124,236.1-4,920,761.62
信用减值损失(新)-41,738,533.1-41,934,892.82-68,814,673.14-33,852,885.36
其他收益7,548,166.5130,649,336.2920,063,924.6614,061,127.87
营业利润平衡项目0000
四、营业利润274,943,946.691,023,404,107.29771,608,225.76545,526,522.21
加:营业外收入7,717,490.5112,410,842.018,418,950.457,915,006.84
减:营业外支出6,325,837.4732,419,560.817,472,745.2312,558,709.97
利润总额平衡项目0000
五、利润总额276,335,599.731,003,395,388.5762,554,430.98540,882,819.08
减:所得税费用60,752,142.38260,275,394.61198,747,894143,338,410.13
六、净利润215,583,457.34743,119,993.89563,806,536.98397,544,408.95
持续经营净利润215,583,457.34743,119,993.89563,806,536.98397,544,408.95
归属于母公司股东的净利润177,360,973570,627,552.6441,882,390.22311,321,223.12
少数股东损益38,222,484.34172,492,441.29121,924,146.7686,223,185.83
(一)基本每股收益0.140.440.340.24
(二)稀释每股收益0.140.440.340.24
八、其他综合收益-7,229,191.8512,772,851.8628,155,158.32-7,698,594.37
归属于母公司股东的其他综合收益-6,878,094.312,572,743.1627,157,780.85-8,110,084.78
九、综合收益总额208,354,265.49755,892,845.75591,961,695.3389,845,814.58
归属于母公司股东的综合收益总额170,482,878.7583,200,295.76469,040,171.07303,211,138.34
归属于少数股东的综合收益总额37,871,386.79172,692,549.99122,921,524.2386,634,676.24
公告日期2025-04-302025-04-102024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑